p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury.

The side effects of cancer therapy on normal tissues limit the success of therapy. Generation of reactive oxygen species (ROS) has been implicated for numerous chemotherapeutic agents including doxorubicin (DOX), a potent cancer chemotherapeutic drug. The production of ROS by DOX has been linked to...

Full description

Bibliographic Details
Main Authors: Joyce M Velez, Sumitra Miriyala, Ramaneeya Nithipongvanitch, Teresa Noel, Chotiros D Plabplueng, Terry Oberley, Paiboon Jungsuwadee, Holly Van Remmen, Mary Vore, Daret K St Clair
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-03-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3068154?pdf=render
_version_ 1818580446537056256
author Joyce M Velez
Sumitra Miriyala
Ramaneeya Nithipongvanitch
Teresa Noel
Chotiros D Plabplueng
Terry Oberley
Paiboon Jungsuwadee
Holly Van Remmen
Mary Vore
Daret K St Clair
author_facet Joyce M Velez
Sumitra Miriyala
Ramaneeya Nithipongvanitch
Teresa Noel
Chotiros D Plabplueng
Terry Oberley
Paiboon Jungsuwadee
Holly Van Remmen
Mary Vore
Daret K St Clair
author_sort Joyce M Velez
collection DOAJ
description The side effects of cancer therapy on normal tissues limit the success of therapy. Generation of reactive oxygen species (ROS) has been implicated for numerous chemotherapeutic agents including doxorubicin (DOX), a potent cancer chemotherapeutic drug. The production of ROS by DOX has been linked to DNA damage, nuclear translocation of p53, and mitochondrial injury; however, the causal relationship and molecular mechanisms underlying these events are unknown. The present study used wild-type (WT) and p53 homozygous knock-out (p53(-/-)) mice to investigate the role of p53 in the crosstalk between mitochondria and nucleus. Injecting mice with DOX (20 mg/kg) causes oxidative stress in cardiac tissue as demonstrated by immunogold analysis of the levels of 4-hydroxy-2'-nonenal (4HNE)-adducted protein, a lipid peroxidation product bound to proteins. 4HNE levels increased in both nuclei and mitochondria of WT DOX-treated mice but only in nuclei of DOX-treated p53((-/-)) mice, implicating a critical role for p53 in causing DOX-induced oxidative stress in mitochondria. The stress-activated protein c-Jun amino-terminal kinase (JNKs) was activated in response to increased 4HNE in WT mice but not p53((-/-)) mice receiving DOX treatment, as determined by co-immunoprecipitation of HNE and pJNK. The activation of JNK in DOX treated WT mice was accompanied by Bcl-2 dissociation from Beclin in mitochondria and induction of type II cell death (autophagic cell death), as evidenced by an increase in LC3-I/LC-3-II ratio and γ-H2AX, a biomarker for DNA damage. The absence of p53 significantly reduces mitochondrial injury, assessed by quantitative morphology, and decline in cardiac function, assessed by left ventricular ejection fraction and fraction shortening. These results demonstrate that p53 plays a critical role in DOX-induced cardiac toxicity, in part, by the induction of oxidative stress mediated retrograde signaling.
first_indexed 2024-12-16T07:17:44Z
format Article
id doaj.art-bab64afe66424102a76a7b70638d29f6
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-16T07:17:44Z
publishDate 2011-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-bab64afe66424102a76a7b70638d29f62022-12-21T22:39:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-03-0163e1800510.1371/journal.pone.0018005p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury.Joyce M VelezSumitra MiriyalaRamaneeya NithipongvanitchTeresa NoelChotiros D PlabpluengTerry OberleyPaiboon JungsuwadeeHolly Van RemmenMary VoreDaret K St ClairThe side effects of cancer therapy on normal tissues limit the success of therapy. Generation of reactive oxygen species (ROS) has been implicated for numerous chemotherapeutic agents including doxorubicin (DOX), a potent cancer chemotherapeutic drug. The production of ROS by DOX has been linked to DNA damage, nuclear translocation of p53, and mitochondrial injury; however, the causal relationship and molecular mechanisms underlying these events are unknown. The present study used wild-type (WT) and p53 homozygous knock-out (p53(-/-)) mice to investigate the role of p53 in the crosstalk between mitochondria and nucleus. Injecting mice with DOX (20 mg/kg) causes oxidative stress in cardiac tissue as demonstrated by immunogold analysis of the levels of 4-hydroxy-2'-nonenal (4HNE)-adducted protein, a lipid peroxidation product bound to proteins. 4HNE levels increased in both nuclei and mitochondria of WT DOX-treated mice but only in nuclei of DOX-treated p53((-/-)) mice, implicating a critical role for p53 in causing DOX-induced oxidative stress in mitochondria. The stress-activated protein c-Jun amino-terminal kinase (JNKs) was activated in response to increased 4HNE in WT mice but not p53((-/-)) mice receiving DOX treatment, as determined by co-immunoprecipitation of HNE and pJNK. The activation of JNK in DOX treated WT mice was accompanied by Bcl-2 dissociation from Beclin in mitochondria and induction of type II cell death (autophagic cell death), as evidenced by an increase in LC3-I/LC-3-II ratio and γ-H2AX, a biomarker for DNA damage. The absence of p53 significantly reduces mitochondrial injury, assessed by quantitative morphology, and decline in cardiac function, assessed by left ventricular ejection fraction and fraction shortening. These results demonstrate that p53 plays a critical role in DOX-induced cardiac toxicity, in part, by the induction of oxidative stress mediated retrograde signaling.http://europepmc.org/articles/PMC3068154?pdf=render
spellingShingle Joyce M Velez
Sumitra Miriyala
Ramaneeya Nithipongvanitch
Teresa Noel
Chotiros D Plabplueng
Terry Oberley
Paiboon Jungsuwadee
Holly Van Remmen
Mary Vore
Daret K St Clair
p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury.
PLoS ONE
title p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury.
title_full p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury.
title_fullStr p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury.
title_full_unstemmed p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury.
title_short p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury.
title_sort p53 regulates oxidative stress mediated retrograde signaling a novel mechanism for chemotherapy induced cardiac injury
url http://europepmc.org/articles/PMC3068154?pdf=render
work_keys_str_mv AT joycemvelez p53regulatesoxidativestressmediatedretrogradesignalinganovelmechanismforchemotherapyinducedcardiacinjury
AT sumitramiriyala p53regulatesoxidativestressmediatedretrogradesignalinganovelmechanismforchemotherapyinducedcardiacinjury
AT ramaneeyanithipongvanitch p53regulatesoxidativestressmediatedretrogradesignalinganovelmechanismforchemotherapyinducedcardiacinjury
AT teresanoel p53regulatesoxidativestressmediatedretrogradesignalinganovelmechanismforchemotherapyinducedcardiacinjury
AT chotirosdplabplueng p53regulatesoxidativestressmediatedretrogradesignalinganovelmechanismforchemotherapyinducedcardiacinjury
AT terryoberley p53regulatesoxidativestressmediatedretrogradesignalinganovelmechanismforchemotherapyinducedcardiacinjury
AT paiboonjungsuwadee p53regulatesoxidativestressmediatedretrogradesignalinganovelmechanismforchemotherapyinducedcardiacinjury
AT hollyvanremmen p53regulatesoxidativestressmediatedretrogradesignalinganovelmechanismforchemotherapyinducedcardiacinjury
AT maryvore p53regulatesoxidativestressmediatedretrogradesignalinganovelmechanismforchemotherapyinducedcardiacinjury
AT daretkstclair p53regulatesoxidativestressmediatedretrogradesignalinganovelmechanismforchemotherapyinducedcardiacinjury